Profile
David Gray currently works at Vigil Neuroscience, Inc., as Chief Scientific Officer from 2023.
Dr. Gray also formerly worked at Pfizer Inc., as Senior Director-Neuroscience Biology, Inscopix, Inc., as Chief Scientific Officer, and Cerevel Therapeutics Holdings, Inc., as Vice President-Chemistry.
Dr. Gray received his doctorate degree from The Scripps Research Institute and undergraduate degree from the University of Minnesota.
David Gray active positions
| Companies | Position | Start |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Chief Tech/Sci/R&D Officer | 2023-02-26 |
Former positions of David Gray
| Companies | Position | End |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Inscopix, Inc.
Inscopix, Inc. BiotechnologyHealth Technology Develops and produces miniature integrated microscopes and related devices | Chief Tech/Sci/R&D Officer | - |
Training of David Gray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inscopix, Inc.
Inscopix, Inc. BiotechnologyHealth Technology Develops and produces miniature integrated microscopes and related devices | Health Technology |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
- Stock Market
- Insiders
- David Gray
















